Oral ONC201 in Adult Recurrent Glioblastoma
Phase of Trial: Phase II
Latest Information Update: 13 Nov 2017
At a glance
- Drugs ONC 201 (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- Sponsors Oncoceutics
- 13 Nov 2017 Results from predictive and pharmacodynamic biomarker analyses presented in an Oncoceutics media release.
- 13 Nov 2017 According to an Oncoceutics media release, data from predictive and pharmacodynamic biomarker analyses will be presented at the 22nd Annual Scientific Meeting and Education Day of the Society of Neuro-Oncology.
- 29 Mar 2017 According to an Oncoceutics media release, results from the first cohort of patients will be reported in scientific forums throughout this year.